BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27838229)

  • 1. Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.
    Alvarenga EM; Souza LK; Araújo TS; Nogueira KM; Sousa FB; Araújo AR; Martins CS; Pacífico DM; de C Brito GA; Souza EP; Sousa DP; Medeiros JV
    Chem Biol Interact; 2016 Dec; 260():129-140. PubMed ID: 27838229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvacryl acetate, a novel semisynthetic monoterpene ester, binds to the TRPA1 receptor and is effective in attenuating irinotecan-induced intestinal mucositis in mice.
    Alvarenga EM; Sousa NA; de Araújo S; Júnior JLP; Araújo AR; Iles B; Pacífico DM; Brito GAC; Souza EP; Sousa DP; Medeiros JVR
    J Pharm Pharmacol; 2017 Dec; 69(12):1773-1785. PubMed ID: 28940490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
    Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.
    Wong DV; Lima-Júnior RC; Carvalho CB; Borges VF; Wanderley CW; Bem AX; Leite CA; Teixeira MA; Batista GL; Silva RL; Cunha TM; Brito GA; Almeida PR; Cunha FQ; Ribeiro RA
    PLoS One; 2015; 10(10):e0139985. PubMed ID: 26440613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
    Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
    Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleviation of 5-fluorouracil-induced intestinal mucositis in rats by vitamin E via targeting oxidative stress and inflammatory markers.
    Al-Asmari AK; Khan AQ; Al-Asmari SA; Al-Rawi A; Al-Omani S
    J Complement Integr Med; 2016 Dec; 13(4):377-385. PubMed ID: 27682716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation.
    Sun M; Zhan H; Long X; Alsayed AM; Wang Z; Meng F; Wang G; Mao J; Liao Z; Chen M
    Phytomedicine; 2024 Jun; 128():155371. PubMed ID: 38518649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
    Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lafutidine, a histamine H2 receptor antagonist with mucosal protective properties, attenuates 5-fluorouracil-induced intestinal mucositis in mice through activation of extrinsic primary afferent neurons.
    Sano T; Utsumi D; Amagase K; Matsumoto K; Tominaga M; Higuchi K; Takeuchi T; Kato S
    J Physiol Pharmacol; 2017 Feb; 68(1):79-90. PubMed ID: 28456772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of regulatory T cells in irinotecan-induced intestinal mucositis.
    Fernandes C; Wanderley CWS; Silva CMS; Muniz HA; Teixeira MA; Souza NRP; Cândido AGF; Falcão RB; Souza MHLP; Almeida PRC; Câmara LMC; Lima-Júnior RCP
    Eur J Pharm Sci; 2018 Mar; 115():158-166. PubMed ID: 29307857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammasome activation is reactive oxygen species dependent and mediates irinotecan-induced mucositis through IL-1β and IL-18 in mice.
    Arifa RD; Madeira MF; de Paula TP; Lima RL; Tavares LD; Menezes-Garcia Z; Fagundes CT; Rachid MA; Ryffel B; Zamboni DS; Teixeira MM; Souza DG
    Am J Pathol; 2014 Jul; 184(7):2023-34. PubMed ID: 24952429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olmesartan decreased levels of IL-1β and TNF-α, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis model.
    de Araújo RF; Reinaldo MP; Brito GA; Cavalcanti Pde F; Freire MA; de Medeiros CA; de Araújo AA
    PLoS One; 2014; 9(12):e114923. PubMed ID: 25531650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
    Pereira VB; Melo AT; Assis-Júnior EM; Wong DV; Brito GA; Almeida PR; Ribeiro RA; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):323-32. PubMed ID: 26666645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
    Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?
    Logan RM; Stringer AM; Bowen JM; Gibson RJ; Sonis ST; Keefe DM
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):239-51. PubMed ID: 18351341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvacrol ameliorates thioacetamide-induced hepatotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in liver of Wistar rats.
    Nafees S; Ahmad ST; Arjumand W; Rashid S; Ali N; Sultana S
    Hum Exp Toxicol; 2013 Dec; 32(12):1292-304. PubMed ID: 23925945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis.
    Li HL; Lu L; Wang XS; Qin LY; Wang P; Qiu SP; Wu H; Huang F; Zhang BB; Shi HL; Wu XJ
    Front Cell Infect Microbiol; 2017; 7():455. PubMed ID: 29124041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of Radix Aucklandiae herbal preparation ameliorate intestinal mucositis induced by 5-fluorouracil in mice.
    Liu JH; Hsieh CH; Liu CY; Chang CW; Chen YJ; Tsai TH
    J Ethnopharmacol; 2021 May; 271():113912. PubMed ID: 33567307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis.
    Bastos RW; Pedroso SH; Vieira AT; Moreira LM; França CS; Cartelle CT; Arantes RM; Generoso SV; Cardoso VN; Neves MJ; Nicoli JR; Martins FS
    Benef Microbes; 2016 Sep; 7(4):549-57. PubMed ID: 27133563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.